| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3a9ba238533c6776ff3033bd1d69328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80e451c10d78573b874e5e165edb9407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a5d8d8d9d61f151a889115b94ff88bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05cf6a3b5a0970b26302bd662d55ad06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b11c9b233554e2d91a8bc67673ccba2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b5d2735121907aa54f0bb30dae1b5f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a9ea2d48434225fbcf8e347433ef2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66e6ef535bd6b321518ebb984c963375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff85a9cd767e36f9921779ad41e0dd5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8383c1bc52619109b3fbdebb27816ec2 |
| publicationDate |
2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8846867-B2 |
| titleOfInvention |
Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies |
| abstract |
This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020061210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3447075-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020180712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11773176-B2 |
| priorityDate |
2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |